These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 8897164

  • 21. Activity of the ketolide telithromycin (HMR-3647) against erythromycin-susceptible and -resistant pneumococci isolated in the UK.
    Johnson AP, Henwood CJ, Tysall L, Warner M.
    Int J Antimicrob Agents; 2001 Jul; 18(1):73-6. PubMed ID: 11463530
    [Abstract] [Full Text] [Related]

  • 22. Surveillance of antibiotic resistance in clinical isolates of Streptococcus pneumoniae collected in Belgium during winter 2000-2001.
    Vanhoof R, Carpentier M, Cartuyvels R, Damée S, Fagnart O, Garrino MG, Glupczynski Y, Gordts B, Govaerts D, Magerman K, Mans I, Surmont I, Van Bossuyt E, Van De Vyvere M, Van Landuyt H, Van Nimmen L, Van Noyen R.
    Acta Clin Belg; 2003 Jul; 58(2):111-9. PubMed ID: 12836494
    [Abstract] [Full Text] [Related]

  • 23. In vitro activities of cethromycin (ABT-773), a new ketolide, against Streptococcus pneumoniae strains that are not susceptible to penicillin or macrolides.
    Mason EO, Lamberth LB, Wald ER, Bradley JS, Barson WJ, Kaplan SL.
    Antimicrob Agents Chemother; 2003 Jan; 47(1):166-9. PubMed ID: 12499186
    [Abstract] [Full Text] [Related]

  • 24. [Macrolide-resistant Streptococcus pneumoniae in the pediatric population in Beijing].
    Yang H, Shen XZ, Wang YH, Yuan L, Yu SJ, Yang YH.
    Zhonghua Er Ke Za Zhi; 2004 Dec; 42(12):936-9. PubMed ID: 15733368
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of in vitro spectra of activity of azithromycin, clarithromycin, and erythromycin tested against strains of Neisseria gonorrhoeae by reference agar dilution, disk diffusion, and Etest methods.
    Mehaffey PC, Putnam SD, Barrett MS, Jones RN.
    J Clin Microbiol; 1996 Feb; 34(2):479-81. PubMed ID: 8789046
    [Abstract] [Full Text] [Related]

  • 26. Tests for susceptibility of Streptococcus pneumoniae to cefdinir: proposed interpretive criteria and quality control parameters for both microdilution and disc diffusion methods.
    Fuchs PC, Barry AL, Tenover FC, Allen SD, Jorgensen JH, Murray PR.
    J Antimicrob Chemother; 1995 Nov; 36(5):781-6. PubMed ID: 8626258
    [Abstract] [Full Text] [Related]

  • 27. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains.
    Giovanetti E, Montanari MP, Mingoia M, Varaldo PE.
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1935-40. PubMed ID: 10428916
    [Abstract] [Full Text] [Related]

  • 28. In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factors.
    Bemer-Melchior P, Juvin ME, Tassin S, Bryskier A, Schito GC, Drugeon HB.
    Antimicrob Agents Chemother; 2000 Nov; 44(11):2999-3002. PubMed ID: 11036012
    [Abstract] [Full Text] [Related]

  • 29. Evaluation of the Dade MicroScan MICroSTREP antimicrobial susceptibility testing panel with selected Streptococcus pneumoniae challenge strains and recent clinical isolates.
    Jorgensen JH, McElmeel ML, Crawford SA.
    J Clin Microbiol; 1998 Mar; 36(3):788-91. PubMed ID: 9508313
    [Abstract] [Full Text] [Related]

  • 30. Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci.
    Ednie LM, Visalli MA, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1950-2. PubMed ID: 8843313
    [Abstract] [Full Text] [Related]

  • 31. Development of doxycycline MIC and disk diffusion interpretive breakpoints and revision of tetracycline breakpoints for Streptococcus pneumoniae.
    Dallas SD, McGee L, Limbago B, Patel JB, McElmeel ML, Fulcher LC, Lonsway DR, Jorgensen JH.
    J Clin Microbiol; 2013 Jun; 51(6):1798-802. PubMed ID: 23554197
    [Abstract] [Full Text] [Related]

  • 32. Reproducibility of broth microdilution and disk diffusion susceptibility tests of nine antimicrobial agents against Streptococcus pneumoniae ATCC 49619.
    Fuchs PC, Barry AL, Brown SD, Allen SD, Bauman M, Jorgensen JH, Tenover FC.
    Diagn Microbiol Infect Dis; 1997 May; 28(1):27-9. PubMed ID: 9218915
    [Abstract] [Full Text] [Related]

  • 33. In vitro activity of selected cephalosporins and erythromycin against staphylococci and pneumococci isolated at 38 North American medical centers participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998.
    Jones RN, Jenkins SG, Hoban DJ, Pfaller MA, Ramphal R.
    Diagn Microbiol Infect Dis; 2000 Jun; 37(2):93-8. PubMed ID: 10863103
    [Abstract] [Full Text] [Related]

  • 34. [The phenotype and genotype patterns of erythromycin-resistant Streptococcus pneumoniae].
    Zhao TM, Liu YN.
    Zhonghua Nei Ke Za Zhi; 2004 May; 43(5):329-32. PubMed ID: 15182500
    [Abstract] [Full Text] [Related]

  • 35. Mechanisms of macrolide resistance in clinical pneumococcal isolates in a university hospital, Ankara, Turkey.
    Sener B, Köseoglu O, Gür D, Bryskier A.
    J Chemother; 2005 Feb; 17(1):31-5. PubMed ID: 15828441
    [Abstract] [Full Text] [Related]

  • 36. Reevaluation of interpretive criteria for Haemophilus influenzae by using meropenem (10-microgram), imipenem (10-microgram), and ampicillin (2- and 10-microgram) disks.
    Zerva L, Biedenbach DJ, Jones RN.
    J Clin Microbiol; 1996 Aug; 34(8):1970-4. PubMed ID: 8818892
    [Abstract] [Full Text] [Related]

  • 37. Comparative study of bactericidal activities, postantibiotic effects, and effects of bacterial virulence of penicillin G and six macrolides against Streptococcus pneumoniae.
    Fuursted K, Knudsen JD, Petersen MB, Poulsen RL, Rehm D.
    Antimicrob Agents Chemother; 1997 Apr; 41(4):781-4. PubMed ID: 9087489
    [Abstract] [Full Text] [Related]

  • 38. Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011-15.
    Karlowsky JA, Adam HJ, Golden AR, Baxter MR, Nichol KA, Martin I, Demczuk W, Mulvey MR, Gilmour MW, Hoban DJ, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA).
    J Antimicrob Chemother; 2018 Jul 01; 73(suppl_7):vii5-vii11. PubMed ID: 29982570
    [Abstract] [Full Text] [Related]

  • 39. The activity of 14-hydroxy clarithromycin, alone and in combination with clarithromycin, against penicillin- and erythromycin-resistant Streptococcus pneumoniae.
    Martin SJ, Garvin CG, McBurney CR, Sahloff EG.
    J Antimicrob Chemother; 2001 May 01; 47(5):581-7. PubMed ID: 11328768
    [Abstract] [Full Text] [Related]

  • 40. Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes.
    Nagai K, Davies TA, Ednie LM, Bryskier A, Palavecino E, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 2001 Nov 01; 45(11):3242-5. PubMed ID: 11600391
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.